Skip to content

Effect of perindopril on prevention of aspiration pneumonia following severe intracerebral hemorrhage (EPOCH) study

Effect of perindopril on prevention of aspiration pneumonia following severe intracerebral hemorrhage (EPOCH) study - EPOCH study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000008222
Enrollment
300
Registered
2012-07-01
Start date
2012-07-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute intracerebral hemorrhage

Interventions

Medication of perindopril controlgroup

Sponsors

Shonan Kamakura General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Acute intracerebral hemorrhagic patients 1) who admit within 72 hour from onset, 2) who initiate nasal-gastric tube feeding within two days dorm admission due to altered mental state, or severe dysphagia, 3) whose age is 20 or more and less than 85 at admission, 4) whose systolic blood pressure is more than 140 mmHg,or diastolic blood pressure is more than 90 mmHg on admission 5) and whose premorbid modified Rankin scale is 2 or less.

Exclusion criteria

Exclusion criteria: 1) Patients who died within 48 hours from admission, 2) Patients whose Japan coma scale is 3-200 or more, or Glasgow coma scale is 6 or less, 3) Patients who has diagnosed pneumonia before initiating nasal-gastric tube feeding, 4) Patients who has diagnosed malignant hypertension, 5) Patients who has diagnosed congestive cardiac failure with NYHA of 3 or more, 6) Patients who has took angiotensin converting enzyme inhibitor drugs, 7) Patients who are ineligible for any other reason in the opinion of the investigator.

Design outcomes

Primary

MeasureTime frame
Prevalence of aspiration pneumonia in acute phase

Secondary

MeasureTime frame
Modified Rankin Scale at 90 days after stroke onset NIHSS scale at 10days after stroke onset Blood pressure Inflammation parameters Duration of antibiotics use

Countries

Japan

Contacts

Public ContactMasahito Nakazaki

Shonan Kamakura General Hospital Deaprtment of Stroke Treatment

mstorke@nak-skgh.com0467-46-1717

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026